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Objectives: To investigate the predictors of general practitioner (GP) consultation and antibiotic use in those de-
veloping sore throat.
Methods: We conducted a prospective population-based cohort study on 4461 participants in two rounds
(2010–11) from 1897 households.
Results: Participants reported 2193 sore throat illnesses, giving a community sore throat incidence of 1.57/
person-year. 13% of sore throat illnesses led to a GP consultation and 56% of these consultations led to antibiotic
use. Participants most likely to have sore throats included women and children (e.g. school compared with retire-
ment age); adjusted incidence rate ratio (aIRR) of 1.33 and 1.52, respectively. Participants with sore throat were
more likely to consult their GP if they were preschool compared with retirement age [adjusted OR (aOR) 3.22],
had more days of sore throat (aOR 1.11), reported more severe pain (aOR 4.24) or reported fever (aOR 3.82).
Antibiotics were more often used by chronically ill individuals (aOR 1.78), those reporting severe pain (aOR 4.14),
those reporting fever (aOR 2.58) or children with earache (aOR 1.85). Among those who consulted, males and
adults who reported feeling anxious were more likely to use antibiotics; aOR 1.87 and 5.36, respectively.
Conclusions:Only 1 in 10 people who have a sore throat see a doctor and more than half of those attending get anti-
biotics. Further efforts to curb antibiotic use should focus on reducing initial GP consultations through public informa-
tion promoting safe self-management, targeted at groups identified above as most likely to attend with sore throats.
Introduction
More than one-third of all antibiotics prescribed for respiratory infec-
tions are because of sore throat,1 and one in two patients present-
ing to their general practitioner (GP) with these symptoms receive
antibiotics.2,3 There is a national drive in the UK to reduce antibiotic
prescribing,4 based on high-level evidence. Meta-analysis of
randomized controlled trials of antibiotics for sore throat have
shown that they only provide a small reduction in symptom severity
and duration (1 day).5 UK observational studies have shown that a
very large number of sore throats need to be treated with antibiotics
to prevent a single complication of infection.6–10 Survey studies
have shown that 1 in 5 patients taking broad-spectrum antibiotics
and 1 in 12 taking narrow-spectrum antibiotics suffer side effects
such as a rash or gastrointestinal upset,11–15 whilst observational
studies using routine data have linked antibiotic use directly to drug
resistance at international16,17and local18 levels.
So far, national guidance,4 GP education schemes19–22 and
alternative prescribing strategies23 have focused on the GP con-
sultation in an effort to reduce antibiotic use. However, the imple-
mentation of consultation-based strategies seems limited since
antibiotic use and practice variation are not only high,3 but on the
increase.24 There is therefore a continuing need to develop and
target strategies that promote patient safe self-management of
sore throat in the community and prevent unnecessary consult-
ation. In fact, the last and only population-based study in England
to investigate sore throat in the community was conducted in
1974 on 198 women aged 20–44 years over a 28 day observation
period.25–27 This small and select sample, with short follow-up,
undertaken four decades ago does not provide sufficient informa-
tion on community burden and risk factors for sore throat, subse-
quent GP consultation and antibiotic use to inform new public
information campaigns. We investigated these issues using a large
population-based prospective national household survey including
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detailed reports of sore throat symptom profiles and GP consult-
ation behaviour over two whole winter seasons in order to inform
and target public health campaigns.
Methods
National household survey
One hundred and forty-six general practices volunteered to participate in
the study through the primary care research network. GPs sent invitations
to a random sample of their register. Around 10% of households invited to
participate did so.28 In total, 4461 participants were recruited between the
two waves of the survey during the winters of 2009/2010 and 2010/2011.
Baseline questionnaires were used to collect basic demographic and med-
ical history information. This included age, gender, postcode, ethnicity, pre-
existing medical conditions and number of people living in the same house-
hold. Subsequently, participants were asked to complete prospective illness
diaries for every day they experienced a ‘sore throat’. Data were collected
daily through online surveys to reduce recall bias, with weekly telephone re-
minders to minimize missing data. Participants were asked about the pres-
ence and severity of sore throat and associated symptoms such as feeling
feverish, headache, having muscle aches, cough, runny nose, blocked nose
and sneezing. During illnesses participants completed a generic health-
related quality-of-life measure (EQ5D-3L).29 Participants were also asked if
they had sought help from their GP for their problems and whether they
used antibiotics. The lead household responder was responsible for
the scores entered for any persons in the house younger than 16, entering
results by proxy for the very young and supervising more competent chil-
dren with the process. Further details of the survey methodology have been
described elsewhere.30
Variable definition
A sore throat episode was defined as two or more consecutive days of mod-
erate to severe sore throat self-reported by the participant.
An episode was assumed to have ended safely when the participant
was free from symptoms for 2 days or more. A new episode was recorded
after at least 7 days without symptoms. The relatively short 7 day window
between episodes was allowed following sensitivity analyses between 14
and 21 day periods that showed no difference in overall sore throat inci-
dence. If the participant consulted with the GP on multiple occasions during
their illness only the first consultation was counted.
Age was categorized as preschool (0–4 years), early school (5–13 years),
adolescence and young adult (14–24 years), early adulthood (25–44 years),
middle age (45–65 years) and retirement age (>65 years). Ethnicity was
defined as white British and other. Postcode was used to define partici-
pants’ geographical region in England (North, West Midlands, East Midlands
and East of England, London, South-East and South-West), population
density (defined as urban or rural) and index of multiple deprivation (cate-
gorized into national quintiles).
Sore throat and all associated symptoms (as described above) were re-
ported absent, mild or moderate–severe. The EQ5D-3L consisted of five di-
mensions (mobility, self-care, usual activities, pain/discomfort and anxiety/
depression), each with three levels of functioning (no problems, some prob-
lems and extreme problems). Both the index score and domain specific val-
ues were evaluated.
Weighting
Since the survey was oversampled in South-West England and under-
sampled in those between 0 and 15 years we weighted analyses to age
and regional structure of England to give locally and nationally representa-
tive estimates. The final weight also accounted for the method of sampling
through households (i.e. participants from a larger household had a greater
chance of being sampled compared with those from smaller households).
Modelling
We used multilevel (patient and general practice level) Poisson regression
models to evaluate sociodemographic determinants of sore throat, and lo-
gistic regression models to investigate sociodemographic and symptom
profiles effects on GP consultation and antibiotic use.
Risk factors found to be significant in univariable analyses were mod-
elled using multilevel multivariable models (at the level of the patient
and general practice), in a forward stepwise fashion. We undertook tests
for interaction between variables if both variables were independently
related to the outcome and had a biologically plausible interdependent
relationship to outcome. All statistical analyses were undertaken on
Stata SE 13.1.
Missing data
Status reports were missing for 12 092 weeks of the 84 245 weeks of
person time, i.e. 14.4% of the data originally available for analysis were
missing (see Figure 1). Sensitivity analyses were undertaken to explore
the impact of these missing data. In one analysis we assumed that a
week missing a status report was a week of no illness, whilst in another
analysis we excluded the weeks with missing status reports from ana-
lysis (completed weeks analysis). There was minimal difference in the
rates produced by either analysis and so we used completed weeks for
subsequent analyses.
Loss to follow-up was defined by absence of weekly status reports in
the last month of study. Less than 3% of the study population was lost to
follow-up.
Ethics
This study underwent ethical approval at Oxford A Research Ethics
Committee (REC), 10/H0604/56. The study registration number was
ISRCTN80214280.
84 245 person 
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observation
72 153 person 
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Figure 1. Loss to follow-up.
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Results
Main findings
The 4461 participants (median age 46 years, IQR 19–62, range
0–99) reported 2193 sore throat illnesses over 489 731 days at
risk, giving a community sore throat incidence of 4.29 (95% CI
3.83–4.81)/1000 person-days and 1.57/person-year. In 280 of
the 2193 (13%) sore throat illnesses, patients visited their GP,
with the remainder self-managing their symptoms. Of those
who consulted their GP, 157 (56%) used antibiotics.
Sore throat incidence in the community
Key findings from univariable Poisson analyses (Table 1) include
the increased risk of reporting a sore throat in females [incidence
rate ratio (IRR) 1.32] and younger people (school age versus retire-
ment age; IRR 1.70). White ethnicity, being a non-smoker, living in
a large household (5 versus 2 people), receiving a flu vaccination
that season and living in an urban region increased the risk of re-
porting a sore throat significantly.
In the multivariable Poisson analysis only female gender [ad-
justed IRR (aIRR) 1.33] and being young (aIRR 1.52) increased the
risk of reporting a sore throat illness (Table 1). Social deprivation,
ethnicity, chronic illness, population density, influenza vaccination
and smoking were not related to risks of reporting a sore throat.
Interaction testing showed a significant interaction between gen-
der and age with females between the ages of 5 and 44 more likely
to report sore throats.
GP consultation behaviour for those with sore throat
illnesses
Results from univariable logistic analyses are summarized in Table 2.
Sociodemographic factors increasing the risk of a person with sore
throat consulting their GP included being young. Disease factors
increasing the risk of GP consultation for sore throat included dur-
ation of sore throat episode, severity of pain, ear ache, fever and
cough. A reduction in health-related quality of life, as measured by
increases in certain EQ5D-3L subdomain scores (usual activities,
self-care, mobility and anxiety) was associated with increased
chance of GP consultation. Multivariable logistic analysis showed
that being young [adjusted OR (aOR) 3.22], days of sore throat
(aOR 1.11), extreme pain (aOR 4.24) and fever (aOR 3.82) signifi-
cantly increased the risk of participants consulting their GP for a
sore throat. Tests of interaction between age and sore throat
symptoms (duration, pain and fever) were not significant.
Antibiotic prescribing for sore throat
Initial multivariable multilevel logistic analyses of antibiotic use in
relation to all sore throat episodes showed that chronic illness was
the only patient factor related to antibiotic use (aOR 1.78). Sore
throat symptom features related to antibiotic use included ear-
ache (aOR 1.85), fever (aOR 2.58) and extreme pain (aOR 4.14)
(see Table 3 for all results). Further testing only showed an inter-
action between age and earache: children were more likely to re-
ceive antibiotics if they reported a sore throat as well as earache
compared with adults.
Subsequent analyses of antibiotic use were specifically re-
stricted to the sore throat episodes which resulted in GP consult-
ation. Results from multivariable multilevel logistic analyses are
summarized in Table 4 and showed that being male (aOR 1.87)
and self-reporting greater anxiety (aOR 5.36) significantly
increased the risk of receiving antibiotics following a visit to the GP
for a sore throat. Interaction testing between age and anxiety
showed that adults who reported anxiety were more likely to re-
ceive antibiotics compared with children.
Discussion
This study demonstrates a high incidence of sore throat in the com-
munity (1.57 episodes/person-year) with the majority of sore throat
illnesses (87.2%) safely managed without GP consultation or prescrip-
tion. Younger age not only increased the risk of reporting a sore throat
(school compared with retirement age: aIRR 1.52) but also increased
the chance of consulting a GP once a sore throat was reported (school
age compared with retirement age: aOR 4.05). Whilst women were
more likely to report a sore throat (aIRR 1.33) they were just as likely
to consult their GP as men once a sore throat had been reported.
Participants were more likely to consult their GP for a sore throat if
their illness was associated with more days of sore throat (aOR 1.11),
extreme pain (aOR 4.24) or fever (aOR 3.82). Despite some targeting
of antibiotic use in sore throat illnesses to those with chronic illness
(aOR 1.78), extreme pain (aOR 4.14) and fever (aOR 2.58) more than
half (57%) of those attending still received antibiotics.
This is the largest population-based survey of sore throat to
date, weighted to represent the national population. The prospect-
ive nature of data collection, through daily health diaries and
weekly telephone calls, allowed us to reduce the recall bias inher-
ent in retrospective interview studies. This survey method also
allowed us to reduce our missing data (14% missing weekly status
reports). Sensitivity analyses of different ways of accounting for
our missing data showed no change in our conclusions. In contrast
to electronic healthcare record studies, we were able to accurately
assess the role of associated symptoms and health-related quality
of life in the management of sore throat episodes, by using de-
tailed disease profile questions. In addition, we were able to dir-
ectly measure antibiotic use through patient self-report, rather
than indirectly through prescription rates. This study has three limi-
tations. Firstly, very young children, residents of North England and
those of lowest socioeconomic status were under-represented in
the study population. Therefore, the survey was weighted to allow
the incidence to be more representative of local and national
populations. Secondly, 1 year of the study was conducted in a pan-
demic influenza outbreak year when there was considerable
media coverage, which may have increased symptom vigilance
and affected consultation behaviour. Lastly, we did not have data
on GP prescription rates. Therefore, the rate of delayed antibiotic
prescribing cannot be ascertained. We have only reported whether
antibiotics were taken or not. We have therefore not been able to
evaluate the effectiveness of the delayed antibiotic prescribing
strategy. Even if a delayed prescribing strategy was used fre-
quently, the fact that more than half of sore throat consultations
ended in antibiotic use shows further strategies are needed.
The only other prospective population-based study in England
was undertaken in Lambeth in 1974 on 198 women, aged 20–44,
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who were asked to keep a prospective health diary for 28 days
each. During the observation period 90 sore throat episodes were
reported [an annual sore throat incidence of 5.9 (95% CI 4.7–7.3)
sore throat episodes per person-year] with 33 subsequent GP con-
sultations [a consultation rate of 37% (95% CI 25%–51%)].
However, since this was a small study in a select population it is dif-
ficult to draw meaningful comparisons. Our results add to the grow-
ing body of evidence from general population studies of respiratory
infections28,31 that the majority of sore throats are managed safely
in the community. The rate of antibiotic prescribing for sore throat
found in our study is comparable to previous primary care studies.2,3
However, these studies retrospectively defined their sore throat
population using GP diagnostic codes which are known to be incon-
sistently used for this condition32 and indirectly approximated anti-
biotic usage through prescription rates. The present study was able
to prospectively define its population based on symptoms
experienced and to directly measure antibiotic use through patient
self-report.
We found that GP consultation for sore throat was predicted by
young age. Studies of all respiratory infections also confirm that
young age is a major driver for primary care use in the UK33 with
qualitative studies showing that parents’ decision to bring their
children to the GP is influenced by perceived threat, disease sever-
ity, the perceived benefits of consulting, and an expectation of as-
sessment, information, advice or treatment.33–37 Our study also
found that severity of throat pain, duration of sore throat and pres-
ence of fever were related to GP consultation. Explanations for
these results can be offered from qualitative research into people
with acute sore throat38 and respiratory tract infections31 showing
that most commonly seek help from their GP for pain relief, per-
ceived symptom severity and non-resolution of symptoms.
Amongst those who see their GP for sore throat, being male and
Table 1. Sore throat incidence in the community and multilevel Poisson regression for sore throat risk factors
Sore throat
illnesses
Time at risk
(days)
Univariable Multivariable
IRR (95% CI)
incidence (episodes/1000
person days) P aIRR (95% CI) P
0–4 years 87 22 240 1.41 (1.14–1.73) 3.96 <0.001 1.20 (0.92–1.56) <0.001
5–13 years 283 56 819 1.70 (1.47–1.97) 4.78 1.52 (1.27–1.82)
14–24 years 169 36 121 1.54 (1.30–1.82) 4.3 1.54 (1.25–1.89)
25–44 years 533 92 143 1.88 (1.65–2.14) 5.28 1.79 (1.53–2.09)
45–65 years 787 176 474 1.47 (1.30–1.65) 4.13 1.36 (1.18–1.57)
>65 years 334 105 933 1 2.81 1
Male 924 240 766 0.76 (0.71–0.83) 3.56 <0.001 0.75 (0.68–0.82) <0.001
Female 1269 248 965 1 4.69 1
North 214 48 046 0.96 (0.79–1.17) 3.83 0.07 – –
West Midlands 116 27 076 0.93 (0.74–1.17) 3.71 –
East and East Midlands 852 160 806 1.13 (0.98–1.30) 4.51 –
London 155 29 088 1.18 (0.95–1.47) 4.70 –
South-East 223 60 849 0.88 (0.72–1.09) 3.51 –
South-West 633 163 866 1 3.99 –
Smokers 88 28 809 0.60 (0.20–0.73) 2.61 <0.001 – –
Non-smokers 1737 366 203 1 4.35 – –
White ethnicity 2028 422 601 1 4.36 0.04 – –
Non-white ethnicity 76 15 242 0.79 (0.63–0.99) 3.45 –
One person in household 116 27 988 1.03 (0.86–1.24) 3.82 <0.001 – –
Two people in household 898 221 787 1 3.71 –
Three people in household 337 73 342 1.15 (1.02–1.30) 4.70 –
Four people in household 596 117 010 1.30 (1.18–1.44) 5.32 –
Five people in household 201 41 532 1.23 (1.06–1.42) 5.03 –
Six people in household 45 8073 1.00 (0.75–1.32) 4.09 –
Received flu vaccination this year 543 110 449 1.02 (0.93–1.11) 4.17 <0.001 – –
Did not receive flu vaccine this year 1608 368 198 1 4.09 –
IMD 1 (most deprived) 59 12 889 0.99 (0.78–1.25) 4.38 0.11 – –
IMD 5 (least deprived) 730 144 627 1 4.43 –
Urban 904 183 773 1.06 (0.96–1.16) 4.45 <0.001 – –
Rural 1275 270 848 1 4.20 –
Well 1836 374 381 1 4.30 0.6 – –
Chronic illness 328 71 249 0.96 (0.84–1.10) 4.13 – –
IMD, index of multiple deprivation (IMD 5¼ least deprived quintile).
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self-reporting anxiety were the only factors related to an increased
chance of taking antibiotics. However, it should be noted that
whilst women were more likely to report a sore throat, gender had
no overall relationship between sore throat and antibiotic use (see
Table 3). Having controlled for pain and duration, increased anxiety
was still an important predictor for receiving antibiotics in adults.
Whilst patient anxiety has not previously been studied as a driver
for high antibiotic prescribing, GPs have been shown to prescribe
antibiotics under perceived patient pressure.39,40 Further
qualitative research could be undertaken to explore the mechan-
ism through which patient anxiety leads GPs to prescribe antibi-
otics for sore throat more frequently. Our study shows no
relationship between sore throat severity, fever, cough, severity of
pain, reduced health-related quality of life on antibiotic use for
those who consulted. Whilst these factors affected participants’
decisions to consult, they did not appear to affect subsequent anti-
biotic prescription in this cohort. Qualitative studies investigating
high antibiotic use have focused on GP behaviour and have shown
Table 2. Risk of GP consultation for sore throat and multilevel logistic regression of risk factors for GP consultation
Variable GP visits Total sore throat episodes %
Univariable analysis Multivariable analysis
OR (95% CI) P aOR (95% CI) P
Chronically ill 65 442 14.71 1.81 (1.26–2.60) 0.001 — —
Well 211 2425 8.70 1 —
0–4 years 37 87 42.53 3.38 (1.92–5.96) <0.001 3.22 (1.81–5.73) <0.001
5–13 years 37 283 13.07 1.26 (0.71–2.23) 1.25 (0.68–2.27)
14–24 years 27 169 15.98 1.58 (0.82–3.04) 1.99 (0.90–4.40)
25–44 years 51 533 9.57 0.93 (0.56–1.53) 0.99 (0.60–1.65)
45–65 years 90 787 11.44 1.04 (0.65–1.66) 1.04 (0.60–1.77)
>65 years 38 334 11.38 1 1
Female 169 1269 13.32 1 0.3 1 0.24
Male 111 924 12.01 0.85 (0.63–1.16) 0.82 (0.59–1.14)
Rural 180 1275 14.12 1 0.1 — —
Urban 100 904 11.06 0.77 (0.57–1.05) —
Non-white 16 76 21.05 1.76 (0.95–3.25) 0.07 — —
White 252 2028 12.43 1 —
IMD 1 (most deprived) 6 59 10.17 0.71 (0.31–1.61) 0.63 — —
IMD 5 (least deprived) 106 730 14.52 1 —
Smokers 10 88 11.36 1.04 (0.48–2.28) 0.91 — —
Non-smokers 194 1737 11.17 1 —
Duration (days) 271 2193 12.36 1.10 (1.08–1.13) <0.001 1.11 (1.08–1.14) <0.001
Earache 101 424 23.82 2.99 (2.19–4.09) <0.001 — —
No earache 179 1684 10.63 1 —
Any cough 236 1612 14.64 2.24 (1.49–3.36) <0.001 —
No cough 44 581 7.57 1 —
Fever 115 475 24.21 4.87 (3.34–7.09) <0.001 3.82 (2.64–5.56) <0.001
No fever 94 1522 6.19 1 1
EQ5D index score 271 2193 12.36 0.10 (0.05–0.19) <0.001 — —
Extreme pain 24 61 39.34 6.95 (3.23–14.97) <0.001 4.24 (1.81–9.94) 0.004
Some pain 47 388 12.11 1.48 (0.94–2.33) 1.38 (0.83–2.29)
No pain 209 2449 8.53 1 1
Extreme loss of usual activity 28 84 33.33 5.44 (2.92–10.12) <0.001 — —
Some loss of usual activity 34 222 15.32 1.97 (1.13–3.41)
No loss of usual activity 218 2592 8.41 1 —
Extreme inability to self-care 9 16 56.25 12.77 (3.32–49.08) <0.001 — —
Some inability to self-care 11 40 27.50 3.77 (1.41–10.10)
Normal self-care 260 2842 9.15 1 —
Extreme loss of mobility 20 50 40.00 6.95 (4.09–11.80) <0.001 — —
Some loss of mobility 18 83 21.69 2.89 (1.39–6.01)
Normal mobility 242 2765 8.75 1 —
Severe anxiety 4 11 36.36 5.67 (1.24–25.98) 0.001 — —
Some anxiety 22 111 19.82 2.45 (1.32–4.55)
No anxiety 254 2776 9.15 1 —
IMD, index of multiple deprivation (IMD 5¼ least deprived quintile).
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a complex interplay of factors including perceived clinical
need,40,41 perceived patient/parent pressure for antibiotics,39 clin-
ical uncertainty42–44 and the desire to maintain a good relationship
with the patient (or parent).42,43,45
Interventions to reduce antibiotic prescribing such as GP outreach
programmes,46 and more recently web-based GP education pro-
grammes,47 have shown some benefit but have not been widely im-
plemented in the UK. In fact, antibiotic prescribing in primary care
increased by 6.2% from 2011 to 2014,24 and even though there was
a 5.4% reduction from 2015 to 2016,48 there were more antibiotic
prescriptions in 2016 compared with 2011. In addition, review of the
literature shows that a multifaceted approach that includes patients
and the public has the greatest impact on antibiotic prescription.49,50
Therefore, there is an urgent need to design additional strategies
targeted at risk groups within the general population to help them
better understand and self-manage sore throat, minimizing
Table 3. Risk of antibiotic use amongst those with sore throat and multilevel logistic regression risk factors for antibiotic use
Variable Antibiotics taken Total sore throat episodes %
Univariable analysis Multivariable analysis
OR (95% CI) P aOR (95% CI) P
Chronically ill 56 328 17.07 1.99 (1.37–2.88) <0.001 1.78 (1.24–2.62) 0.004
Well 167 1836 9.10 1 1
0–4 years 23 87 26.44 2.61 (1.21–5.63) 0.1 2.23 (0.99–5.01) 0.23
5–13 years 25 283 8.83 1.08 (0.54–2.14) 1.01 (0.47–2.19)
14–24 years 19 169 11.24 1.36 (0.62–2.97) 1.61 (0.74–1.49)
25–45 years 46 533 8.63 1.08 (0.60–1.95) 1.08 (0.58–2.03)
46–65 years 84 787 10.67 1.27 (0.75–2.17) 1.22 (0.70–2.11)
>65 years 29 334 8.68 1 1
Female 132 1269 10.40 1 0.94 1 0.82
Male 94 924 10.17 0.99 (0.70–1.39) 1.04 (0.73–1.49)
Rural 137 1275 10.75 1 0.60 —
Urban 89 904 9.85 0.91 (0.63–1.31) —
Non-white 14 76 18.42 1.75 (0.81–3.78) 0.15 —
White 206 2028 10.16 1 —
IMD 1 (most deprived) 4 59 6.78 0.69 (0.24–1.98) 0.85 —
IMD 5 (least deprived) 73 730 10.00 1 —
Smokers 11 88 12.50 1.21 (0.54–2.74) 0.64 —
Non-smokers 215 2105 10.21 1 —
Duration (days) 2193 2193 100.00 1.09 (1.06–1.11) <0.001 1.08 (1.06–1.10)
Earache 80 424 18.87 2.36 (1.68–3.29) <0.001 1.85 (1.25–2.75) 0.002
No earache 146 1684 8.67 1 1
Any cough 191 1612 11.85 1.90 (1.18–3.03) 0.008 —
No cough 35 572 6.12 1 —
Fever 83 367 22.62 3.02 (2.19–4.17) <0.001 2.58 (1.74–3.82) <0.001
No fever 143 1826 7.83 1 1
EQ5D index score 2193 2193 100.00 0.13 (0.06–0.28) <0.001 —
Extreme pain 21 52 40.38 5.88 (2.81–12.30) <0.001 4.14 (1.74–3.81) 0.002
Some pain 37 331 11.18 1.33 (0.82–2.15) 1.18 (0.74–1.89)
No pain 168 1810 9.28 1 1
Extreme loss of usual activity 20 76 26.32 3.34 (1.77–6.30) <0.001 —
Some loss of usual activity 27 191 14.14 1.62 (0.94–2.78) —
No loss of usual activity 179 1926 9.29 1 —
Extreme inability to self-care 9 12 75.00 13.93 (3.20–60.66) <0.0004 —
Some inability to self-care 10 32 31.25 3.44 (1.18–10.02) —
Normal self-care 207 2149 9.63 1 —
Extreme loss of mobility 16 45 35.56 5.20 (2.89–9.38) <0.001 —
Some loss of mobility 12 73 16.44 1.92 (0.93–3.96) —
Normal mobility 198 2075 9.54 1 —
Severe anxiety 4 9 44.44 6.15 (1.31–28.96) 0.004 —
Some anxiety 18 100 18.00 2.48 (1.26–4.88) —
No anxiety 204 2084 9.79 1 —
IMD, index of multiple deprivation (IMD 5¼ least deprived quintile).
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unnecessary GP consultations and subsequent antibiotic prescribing.
Whilst the general poster and leaflet campaign in England
encouraging the public not to take antibiotics for common colds had
little effect on antibiotic prescriptions,51 studies of targeted patient
education have shown reductions in antibiotic use.52–54 Public infor-
mation particularly targeted at groups that our study found to be at
risk of sore throat or most likely to consult, such as women and chil-
dren, could aim to promote safe self-management and reduce anx-
iety associated with sore throat. This could emphasize that moderate
to severe pain, prolonged duration and fever are frequent self-
limiting features of sore throat. There is also a need to moderate the
messages by highlighting ‘red-flag’ symptoms (e.g. trismus, difficulty
breathing, neck swelling, torticollis), so the threshold for help-seeking
behaviour may align more accurately with patients who would bene-
fit from antibiotics in sore throat infections.55–57 Messages which
highlight the fact that antibiotics provide minimal additional benefit
over and above simple over-the-counter medications and often re-
sult in unwanted side effects may be more effective than those
focusing on the less immediate problem of resistance.58 Tackling the
problem of over-prescribing of antibiotics in primary care requires de-
velopment of joined-up strategies targeting the general public, those
who present with sore throat and their doctors.
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